Health

FDA Approves Ibtrozi (taletrectinib) for Advanced ROS1-Positive Non-Small Cell Lung Cancer

DailyTrendDailyTrend
Jun 12, 2025 - 14:00
 0  0
FDA Approves Ibtrozi (taletrectinib) for Advanced ROS1-Positive Non-Small Cell Lung Cancer
NEW YORK--(BUSINESS WIRE) June 11, 2025 -- Nuvation Bio Inc. (NYSE: NUVB), a global oncology company focused on tackling some of the toughest challenges in cancer treatment, today announced that the U.S. Food and Drug Administration (FDA) has...
Read More

What's Your Reaction?

Like Like 0
Dislike Dislike 0
Love Love 0
Funny Funny 0
Angry Angry 0
Sad Sad 0
Wow Wow 0
DailyTrend
DailyTrend

Related Posts

A 1990 Measles Outbreak Shows How the Disease Can Roar Back

A 1990 Measles Outbreak Shows How the Disease Can Roar ...

DailyTrend Aug 21, 2025  0  0

Wildfire Fighters, Unmasked in Toxic Smoke, Are Getting Sick and Dying

Wildfire Fighters, Unmasked in Toxic Smoke, Are Getting...

DailyTrend Aug 17, 2025  0  0

Early Alert: Cardiac Cannula Issue from Medtronic

Early Alert: Cardiac Cannula Issue from Medtronic

DailyTrend Aug 16, 2025  0  0

Why Wildfire Fighters Are Getting Dangerously Sick

Why Wildfire Fighters Are Getting Dangerously Sick

DailyTrend Aug 17, 2025  0  0

B. Braun Medical Issues Voluntary Nationwide Recall of Lactated Ringer’s Injection USP 1000 mL and 0.9% Sodium Chloride Injection USP 1000 mL Due to the Presence of Particulate Matter

B. Braun Medical Issues Voluntary Nationwide Recall of ...

DailyTrend Aug 20, 2025  0  0

A New Way to Reduce Children’s Deaths: Cash

A New Way to Reduce Children’s Deaths: Cash

DailyTrend Aug 18, 2025  0  0